1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Vascular Access

Discussion in 'Contract Manufacturer Reps' started by Anonymous, Mar 11, 2014 at 3:28 PM.

  1. Anonymous

    Anonymous Guest

    Does Bard have independents out here or just directs? Would like to hire some
     
  2. Anonymous

    Anonymous Guest

    Bard is direct as are Angiodynamics and Arrow. MedCrap are all independents
     
  3. Anonymous

    Anonymous Guest

    Bullshit. If you did you woudl have contacted directly. Lazy Moles bite.